Considering a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits particular behaviors. check here It functions primarily as a NSAID agent, selectively blocking cyclooxygenase-2 (COX-2), an catalyst participating in prostaglandin synthesis . This targeted inhibition results in reduced inflammation and discomfort , offering clinical effects